Fig. 3From: TNFα expressed on the surface of microparticles modulates endothelial cell fate in rheumatoid arthritisPlasma levels of microparticles (MPs) in patients with rheumatoid arthritis (RA) at time zero (baseline (T0)) and after 4 months of treatment (T4) and in healthy controls (HC) and surface expression of TNFα. a Relative distribution of total MPs (TMPs), platelet MPs (PMPs), leukocyte MPs (LMPs) and endothelial MPs (EMPs) in 20 patients with rheumatoid arthritis (RA) and 20 healthy controls (HC). b, c Relative distribution of TMPs, PMPs, LMPs, EMPs (a) and EMPs annexin-V (AV)+ (c) in patients with RA at time zero (baseline (T0) and 4 months after treatment (T4). d Relative distribution of the percentage of the expression of TNFα on the surface of MPs from patients with RA and HC. e Relative distribution of TNFα expression on MPs from patients with RA at T0 and T4. Each data point represents a single subject; horizontal lines show the median. Groups were compared using Student’s t test; *p < 0.05Back to article page